Whole blood RNA sequencing reveals a differential transcriptomic profile associated with cervical insufficiency: a pilot study
Open Access
- 24 February 2021
- journal article
- research article
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 19 (1) , 1-11
Abstract
Background: The uterine cervix is a mechanical and immunological barrier against ascending infection during pregnancy. Cervical insufficiency (CI), a painless cervical dilation that occurs in the mid-trimester, is an important cause of extremely preterm birth. We hypothesized that women with CI have a differential transcriptomic profile. Therefore, we compared the transcriptomic profile of peripheral blood in women with CI and that of controls. Methods: RNA sequencing was used to generate the global gene expression profiles of 11 women with CI and 4 controls, and differential expression analysis was performed to identify genes showing significant expression changes between the CI (n = 11) and control (n = 4) groups as well as between the CI-preterm (n = 7) and CI-term (n = 4) groups. Gene set enrichment was assessed in terms of Gene Ontology processes, and a subset of differentially expressed genes in CI was validated in a different sample-set by qRT-PCR and ELISA. Results: Thirty genes were differentially expressed between the CI and control groups. Differentially upregulated genes in the CI group included neutrophil-mediated immunity-associated (DEFA3 and ELANE) and bicarbonate transport-related genes. The serum concentration of alpha defensin 3 was significantly higher in women with CI than in controls (P = 0.014). Analysis of differential gene expression according to pregnancy outcomes revealed 338 differentially expressed genes between the CI-term and CI-preterm groups. Immune and defense response to organism-associated genes and influenza A and NOD-like receptor signaling pathways were upregulated in the CI-term group. Conclusions: Our results revealed significant differences in the whole blood transcriptomic profiles of women with CI compared to those of controls. Different immune responses in women with CI may affect pregnancy outcomes.Keywords
Funding Information
- Bio & Medical Technology Development Program of the National Research Foundation (NRF-2017M3A9E8033229, NRF-2017M3A9E8049714)
- Bio & Medical Technology Development Program of the National Research Foundation (NRF-2019M3A9E8020538)
This publication has 39 references indexed in Scilit:
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic reviewThe Lancet, 2012
- Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiationNature Biotechnology, 2010
- RNA‐Seq: A Method for Comprehensive Transcriptome AnalysisCurrent Protocols in Molecular Biology, 2010
- Dying and Necrotic Neutrophils Are Anti-Inflammatory Secondary to the Release of α-DefensinsThe Journal of Immunology, 2009
- RNA-Seq: a revolutionary tool for transcriptomicsNature Reviews Genetics, 2009
- Expression of CD1d and Ligand-Induced Cytokine Production Are Tissue Specific in Mucosal Epithelia of the Human Lower Reproductive TractInfection and Immunity, 2008
- Copy number polymorphism and expression level variation of the human α-defensin genes DEFA1 and DEFA3Human Molecular Genetics, 2005
- Neutrophil Extracellular Traps Kill BacteriaScience, 2004